Identify the immunological effects that radiation has, which can be exploited in combination with emerging immunotherapy agents. |
|
|
|
|
|
|
Describe the timing of radiation and immune-checkpoint inhibitors are important in improving outcomes in patients, as established in early preclinical models and some early patient outcome series. |
|
|
|
|
|
|